Proteome Sciences plc
PRM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£3,406 | -£2,443 | £1,325 | £72 |
| Dep. & Amort. | £837 | £484 | £284 | £213 |
| Deferred Tax | £0 | £0 | -£512,791 | -£476,672 |
| Stock-Based Comp. | £40 | £218 | £303 | £570 |
| Change in WC | £828 | £454 | -£209 | -£328 |
| Other Non-Cash | £875 | £806 | £513,228 | £476,938 |
| Operating Cash Flow | -£826 | -£481 | £3,882,000 | £10,522,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£224 | -£237 | -£1,746,000 | -£1,720,000 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | -£187 | -£19,927,000 | £5,990,000 |
| Investing Cash Flow | -£224 | -£424 | -£21,673,000 | £4,270,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £750 | -£824 | -£209 | -£400 |
| Stock Issued | £0 | £13,740,000 | £13,147,000 | £9,956,000 |
| Stock Repurch. | £0 | -£5,249,000 | -£4,133,000 | -£1,674,000 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£599 | -£238 | £0 | £0 |
| Financing Cash Flow | £151 | -£1,062 | -£209 | -£400 |
| Forex Effect | £0 | £0 | £10,330,000 | -£4,232,000 |
| Net Chg. in Cash | -£899 | -£1,967 | £19,584,000 | £49,064,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £2,027 | £3,994 | £259,206,000 | £210,142,000 |
| End Cash | £1,128 | £2,027 | £278,790,000 | £259,206,000 |
| Free Cash Flow | -£1,050 | -£718 | £2,136,000 | £8,802,000 |